Hypothesis

Aging’s phenotypic hallmarks arise from a circadian‑gated program in which senescent astrocytes of the suprachiasmatic nucleus (SCN) secrete extracellular vesicles enriched in specific microRNAs that drive systemic inflammation, epigenetic drift, and proteostatic collapse.

Mechanistic core

1. Circadian pressure on SCN astrocytes – Age‑related decline of SIRT1 in hypothalamic neurons shifts SCN firing phase, prolonging excitatory glutamatergic tone during the subjective night (see SIRT1‑metabolism‑circadian link)[https://pmc.ncbi.nlm.nih.gov/articles/PMC11040316/]. This chronic misalignment elevates oxidative stress specifically in SCN astrocytes, pushing them toward a senescent phenotype characterized by p16^INK4a^ upregulation and SASP secretion.

2. Astrocyte‑derived extracellular vesicles (EVs) – Senescent SCN astrocytes load EVs with a microRNA signature (e.g., miR‑34a‑5p, miR‑146a‑5p) that suppresses SIRT1 expression in target cells and activates NF‑κB signaling. EV release follows a circadian rhythm, peaking during the early subjective day when SCN output is highest.

3. Systemic propagation – EVs cross the blood‑brain barrier via fenestrated capillaries in the circumventricular organs and enter circulation. Peripheral tissues uptake these EVs, leading to:

   • Epigenetic drift – miR‑34a‑5p directs DNMT3A activity, generating methylation changes that align with DamAge signatures and predict mortality via pro‑inflammatory pathways[https://www.creativebiomart.net/blog/nat-aging-a-new-epigenetic-clock-reshapes-the-way-people-predict-biological-age][https://news.harvard.edu/gazette/story/2024/02/looking-to-rewind-the-aging-clock/].
   • Inflammatory priming – miR‑146a‑5p modulates IRAK1/TRAF6, creating a low‑grade inflammasome tone that amplifies NF‑κB activity in macrophages and endothelial cells.
   • Proteostatic challenge – Reduced SIRT1 deacetylase activity diminishes FOXO‑mediated autophagy and HSP70 chaperone expression, lowering the threshold for protein aggregation and reproducing the biophysical tipping point described for proteostasis collapse[https://www.pnas.org/doi/10.1073/pnas.1906592116].

Thus, a single upstream event—circadian‑driven SCN astrocyte senescence—coordinates multiple hallmarks through a timed EV‑mediated signaling cascade.

Testable predictions

• Prediction 1: Genetic ablation of p16^INK4a^‑positive astrocytes in the SCN of middle‑aged mice will flatten the circadian phase‑shift of peripheral liver clocks (measured by PER2::LUC bioluminescence) and reduce circulating EV‑associated miR‑34a‑5p levels.
• Prediction 2: Pharmacological clearance of senescent astrocytes using a senolytic (e.g., navitoclax) administered at ZT6 will lower plasma DamAge‑associated CpG methylation scores after 4 weeks, while leaving AdaptAge‑associated sites unchanged.
• Prediction 3: Isolating EVs from SCN astrocytes of old mice and injecting them into young recipients will recapitulate age‑like epigenetic drift (increased DamAge CpGs) and accelerate proteostasis reporters (e.g., poly‑Q aggregation) in skeletal muscle within two weeks.
• Prediction 4: Blocking EV release with GW4869 (neutral sphingomyelinase inhibitor) specifically in the SCN will rescue SIRT1 activity in peripheral tissues and improve grip strength and treadmill endurance in aged mice without altering food intake.

Falsifiability

If any of the above interventions fail to produce the predicted directional changes—e.g., senescent astrocyte removal does not attenuate peripheral clock phase shifts or EV‑miRNA levels—the hypothesis that SCN astrocyte senescence is a primary upstream controller would be refuted, supporting the view that hallmarks are semi‑independent processes.

Broader implication

Targeting the circadian‑sensitive astrocytic senescence node could simultaneously modulate epigenetic clocks, inflammatory tone, and proteostatic capacity, offering a unified leverage point for interventions that presently address each hallmark in isolation.